Literature DB >> 35031925

Kinases and therapeutics in pathogen mediated gastric cancer.

Charu Sonkar1, Nidhi Varshney1, Siva Koganti2, Hem Chandra Jha3.   

Abstract

INTRODUCTION: Many pathogens have coexisted with humans for millennia and can cause chronic inflammation which is the cause of gastritis. Gastric cancer (GC) is associated with 8.8% of cancer related deaths, making it one of the leading causes of cancer related deaths worldwide. This review is intended to give brief information about Helicobacter pylori (H. pylori), Epstein-Barr virus (EBV), human cytomegalovirus (HCMV) role in GC and associated kinases. These organisms can trigger multiple cellular pathways aiming for unnatural cellular proliferation, apoptosis, migration and inflammatory response. Kinases also can activate and deactivate the signalling leading to aforementioned pathways. Therefore, studying kinases is inevitable.
MATERIAL AND METHODS: This review is the comprehensive collection of information from different data sources such as journals, book, book chapters and verified online information.
CONCLUSION: Kinase amplifications could be used as diagnostic, prognostic, and predictive biomarkers in various cancer types. Hence targeting kinase and related signalling molecules could be considered as a potential approach to prevent cancer through these organisms. Here we summarize the brief information about the role of kinases, signalling and their therapeutics in GC concerning H. pylori, EBV and HCMV.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  EBV; Gastric cancer; H. pylori; HCMV; Kinases

Mesh:

Year:  2022        PMID: 35031925     DOI: 10.1007/s11033-021-07063-9

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  78 in total

1.  Helicobacter pylori Infection and Gastric Adenocarcinoma.

Authors:  Pelayo Correa; M Blanca Piazuelo
Journal:  US Gastroenterol Hepatol Rev       Date:  2011-06

2.  Discovery and validation of methylated-differentially expressed genes in Helicobacter pylori-induced gastric cancer.

Authors:  Duanrui Liu; Xiaoli Ma; Fei Yang; Dongjie Xiao; Yanfei Jia; Yunshan Wang
Journal:  Cancer Gene Ther       Date:  2019-07-16       Impact factor: 5.987

Review 3.  Burden of Gastric Cancer.

Authors:  Aaron P Thrift; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2019-07-27       Impact factor: 11.382

Review 4.  Helicobacter pylori and Gastric Cancer: Adaptive Cellular Mechanisms Involved in Disease Progression.

Authors:  Paula Díaz; Manuel Valenzuela Valderrama; Jimena Bravo; Andrew F G Quest
Journal:  Front Microbiol       Date:  2018-01-22       Impact factor: 5.640

Review 5.  Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer.

Authors:  Shyam Singh; Hem Chandra Jha
Journal:  J Oncol       Date:  2017-03-21       Impact factor: 4.375

6.  Aurora kinase A regulates Survivin stability through targeting FBXL7 in gastric cancer drug resistance and prognosis.

Authors:  M Kamran; Z-J Long; D Xu; S-S Lv; B Liu; C-L Wang; J Xu; E W-F Lam; Q Liu
Journal:  Oncogenesis       Date:  2017-02-20       Impact factor: 7.485

Review 7.  Gastric cancer: epidemiology, prevention, classification, and treatment.

Authors:  Robert Sitarz; Małgorzata Skierucha; Jerzy Mielko; G Johan A Offerhaus; Ryszard Maciejewski; Wojciech P Polkowski
Journal:  Cancer Manag Res       Date:  2018-02-07       Impact factor: 3.989

8.  Epstein-Barr Virus Infection Promotes Epithelial Cell Growth by Attenuating Differentiation-Dependent Exit from the Cell Cycle.

Authors:  Mark R Eichelberg; Rene Welch; J Tod Guidry; Ahmed Ali; Makoto Ohashi; Kathleen R Makielski; Kyle McChesney; Nicholas Van Sciver; Paul F Lambert; Sündüz Keleș; Shannon C Kenney; Rona S Scott; Eric Johannsen
Journal:  mBio       Date:  2019-08-20       Impact factor: 7.867

9.  Oral rinses in growth inhibition and treatment of Helicobacter pylori infection.

Authors:  Dharmendra Kashyap; Budhadev Baral; Tarun Prakash Verma; Charu Sonkar; Debi Chatterji; Ajay Kumar Jain; Hem C Jha
Journal:  BMC Microbiol       Date:  2020-03-04       Impact factor: 3.605

10.  REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype.

Authors:  J Yu; Q Liang; J Wang; K Wang; J Gao; J Zhang; Y Zeng; P W Y Chiu; E K W Ng; J J Y Sung
Journal:  Oncogene       Date:  2016-05-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.